Navigation Links
Hematogenix Launches Comprehensive Molecular Profiling Test iDNAfyTM

TINLEY PARK, Ill., July 17, 2014 /PRNewswire-iReach/ -- Hematogenix Laboratory Services (Hematogenix), a leader in integrated pathology services for drug development and personalized diagnostics, today announced the launch of its comprehensive molecular profiling service, iDNAfyTM.  Available through the company's Pharma and Diagnostic Service arms, the service provides Oncology clients with actionable information to optimize targeted cancer therapy for their patients.

iDNAfyTM brings a holistic approach to guided therapies by screening and confirming high-relevance somatic mutations.  The targeted identification of these mutations in tumor suppressors and key oncogenes will provide crucial information for the oncologist to use as a guide when deciding on the appropriate therapies and personalized cancer treatments for their patients.  

"Physicians are able to personalize treatments for their patients like never before using the molecular profiles of cancer tissue samples, and we are delighted to introduce a service that adds such value to the process," said Dr. Hytham Al‐Masri, CEO and President of Hematogenix.  "IDNAfyTM will provide an efficient and cost effective approach to identifying genetic mutations that help connect patients' tumors with the appropriate drug of choice by their physician, and our report will assist in matching them with innovative clinical trials." 

Hematogenix has incorporated Agena Bioscience's MassARRAY® system into its existing technologies to support the launch of its Tumor Profiling Services, which complements existing platforms with a more comprehensive testing menu.

"Physicians have the benefit of working with our Pathologists to choose from existing technologies such as IHC, FISH/ISH, and PCR to personalize testing in our full service oncology laboratory," said Dr. Al-Masri.  "Today, results of molecular profiling can contraindicate chemotherapy altogether in favor of other therapies, and iDNAfyTM is a critical aid to this process."

About Hematogenix
Hematogenix is a CAP, CLIA (Clinical Laboratory Improvement Amendments) certified laboratory with a full complement of board certified clinical, anatomic and research pathologists to provide consultation and guidance for all aspects of their pharma and diagnostic services. The company offers a comprehensive array of biomarker development and testing services designed to navigate the complexities of human subject clinical trials. Hematogenix provides logistic management of tissue and sample procurement, distributes collection kits and contributes to standards and procedures required for initiating a clinical trial. Powered by a state‐of‐the‐art laboratory information system, Hematogenix facilities and practices comply with rigorous chain of custody and specimen management practices. Learn more about Hematogenix biomarker and diagnostic services at

Media Contact: Kathryn Evans, Hematogenix, 708-444-0444,

News distributed by PR Newswire iReach:

SOURCE Hematogenix
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery
2. ReachMD Launches New Oncology Show Featuring Well-known Cancer Expert and Host, Selma Schimmel
3. Elsevier Launches the New Generation SciVal, Providing Dynamic Real-Time Analytics and Insights into the Global Research Landscape
4. HealthEconomics.Com Launches Live Streaming Educational Series in HE-Xpo®, the Pharma Industry’s Only Online Virtual Community for Health Economics and Outcomes Research
5. The Houston Methodist Human Performance Lab Launches Innovative Study on Triathletes, Investigating the Effects of Aging and Training Variables on Triathlon Performance
6. Shire Launches Online Educational Resource Center for US Patients with Ulcerative Colitis
7. Finesse Solutions Launches Next Generation G3Pro Universal SmartControllers to Enhance Productivity in Pilot and Production Scale Cell Culture
8. Foundation for the NIH Launches Bone Quality Project
9. Applied Silicone Launches Ultra-Soft LSR
10. Deadline Solutions, Inc. Launches Amazon Store with the WVS ® Branded LogTag® Temperature Data Recorder
11. The Conferences Forum Launches Patients as Partners Event
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... recipients of 13 prestigious awards honoring scientists who have made ... in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
Breaking Biology Technology:
(Date:8/23/2017)... ARMONK, N.Y. , Aug. 23, 2017  The general public,s help ... the human microbiome—the bacteria that live in and on the human body ... ... bacteria in the human microbiome, starting with the gut. The project's goal ... in disease. Photo credit: IBM ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
Breaking Biology News(10 mins):